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The effect of genetic immunization of neonatal mice was tested with a plasmid vector expressing the rabies virus
glycoprotein. Mice inoculated within 24 hr after birth with the plasmid DNA developed antibodies as well as T helper cells
to the rabies virus glycoprotein. The response could not be distinguished from that seen upon vaccination of adult mice.
Taken together, these data clearly show that the immune system, known to be prone to induction of immunological tolerance
to some antigens applied during the early neonatal period, can readily respond to rabies virus glycoprotein induced by a
plasmid vector. q 1997 Academic Press
INTRODUCTION complex (MHC) class I determinants and hence to induc-
tion of cytolytic T cells (Ulmer et al., 1993). Vector vac-
Vaccination is currently the most efficacious medical
cines thus seem to fulfill many of the requirements ex-
intervention for preventing human disease. Vaccines
pected of good vaccines. They carry none of the risks
have eradicated variola major and have significantly re-
associated with live attenuated vaccines and thus far
duced the incidence of a number of infectious childhood
they have been shown to be safe (although further long-
diseases such as rubella and poliomyelitis. Traditionally,
term studies are required to ascertain the lack of unex-
vaccines are based on either attenuated or inactivated
pected side effects). They induce a full spectrum of im-
pathogens. Not all infectious agents can be attenuated
mune responses, including antibodies, T helper cells,
with the high degree of reliability required of vaccines
and cytolytic T cells, and they provide (at least in small
that aim at protecting healthy humans against a threat
rodents) life-long immunity. Another wanted trait in vac-
they might never encounter. Inactivated vaccines are
cines is their ability to induce immunity in very young
safer, but as a rule, fail to induce cytolytic T cells that
individuals before they come in contact with the patho-
are crucial in limiting the spread of numerous viruses,
gens. The immune system of neonates is partially imma-
facultatively intracellular bacteria, and some parasites.
ture; immunization with some antigens, such as alloanti-
Furthermore, inactivated vaccines rarely induce long-
gens, expressed on lymphoid cells induces tolerance
term protection. A novel vaccine approach based on im-
(Billingham et al., 1953; Holan et al., 1978; Streilein, 1991;
munization with plasmid vectors encoding a foreign pro-
Streilein and Klein, 1977); other antigens, such as poly-
tein under the control of a strong promoter (Tang et al.,
saccharides, remain ignored due to a developmental de-
1992) might overcome some of the shortcomings of atten-
lay in maturation of the appropriate B cell subset (Mosier
uated or inactivated vaccines. Vector DNA was shown
et al., 1977). Data presented here show that DNA vac-
to be taken up by cells upon intramuscular or intradermal
cines given to newborn mice do not result in tolerance
inoculation (Davis et al., 1993; Williams et al., 1991; Wolff
but rather in stimulation of an antigen-specific immune
et al., 1990), causing expression of the vector-encoded
response.
antigens, which in turn results in stimulation of an im-
mune response (Frynan et al., 1993; Ulmer et al., 1993; MATERIAL AND METHODS
Wang et al., 1993; Xiang et al., 1994). Mice
Intriguingly, the immune response upon genetic immu-
Six- to 8-week-old C3H/He mice were purchased from
nization is exceptionally long-lasting in mice that upon
The Jackson Laboratory (Bar Harbor, Maine). Groups of
inoculation with a single dose of vector were shown to
two females were cohoused at the Animal Facility of
maintain immunological memory for life (Davis et al.,
The Wistar Institute with one male until pregnancy was
1993, Yakauckas et al., 1993). In contrast to inactivated
ascertained. Pups were separated from the dams at 4
pathogens, proteins encoded by plasmid vectors are syn-
weeks of age according to sex.
thesized within transfected cells, leading to the associa-
Cellstion of antigenic fragments with major histocompatibility
Baby hamster kidney (BHK)-21 cells were maintained
in Dulbecco’s modified Eagle’s medium (DMEM) supple-1 To whom reprint requests should be addressed.
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mented with 10% fetal bovine serum (FBS), antibiotics, Cytokine release assay
and glutamine. The HT-2 cell line, which proliferates to
Splenocytes (6 1 106/well) were cultured in 1.6 ml of
interleukin (IL)-2 and IL-4, was maintained in DMEM con-
DMEM medium supplemented with 2% FBS and 1006
taining 10% FBS, 1006 M 2-mercaptoethanol, and 10%
M 2-mercaptoethanol in 24-well Costar plates without
rat concanavalin A supernatant. The CT4S cell line that
antigen or with 1 mg/ml of inactivated ERA virus. Cell-free
responds only to IL-4 was grown in HEPES-free DMEM
supernatants were harvested and tested for induction of
supplemented with 10% FBS and 2 units/ml of recombi-
proliferation of the IL-2- and -4-sensitive HT-2 cell line or
nant IL-4.
the IL-4-dependent CT4S cell line, as described (Xiang
et al., 1994).Viruses
Rabies viruses of the Evelyn Rokitniki Abelseth (ERA) RESULTS
strain and challenge virus standard (CVS)-11 strain were
To test the effects of genetic immunization on the neo-propagated on BHK-21 cells. ERA virus was purified and
natal immune system, C3H/He mice were inoculatedinactivated with b-propionolactone (BPL) as described
within 24 hr after birth with a plasmid vector expressing(Xiang and Ertl, 1992). CVS-11 virus was titrated on BHK-
the rabies virus glycoprotein. Control pups were immu-21 cells and unpurified infectious virus was used for
nized either with PBS or with an equal dose of the emptyneutralization assays.
pSG5 vector. The antibody response to the rabies virus
Plasmid antigen tested 4–6 weeks after immunization was clearly
positive in most of the mice inoculated with theThe pSG5rab.gp vector that expresses the full-length
pSG5rab.gp vector, while pSG5-inoculated pups failedrabies virus glycoprotein under the control of the simian
to generate titers that were significantly above those ofvirus 40 promoter (Burger et al., 1991) and the empty
negative control pups (results from individual mice frompSG5 vector were propagated in Escherichia coli strain
three separate experiments are shown in Fig. 1). Never-DH5a in the presence of ampicillin. The plasmids were
theless, pSG5 vector-inoculated pups had, in most exper-purified using the Promega Wizard Maxiprep DNA Purifi-
iments, slightly elevated antibody levels, as determinedcation system according to the manufacturer’s protocol.
by ELISA, compared to naive pups or pups inoculatedThe DNA was quantitated by agarose gel electrophoresis
with PBS, which most likely reflects the immunomodula-against a known marker.
tory activity of DNA of bacterial origin (Pisetsky, 1996).
In contrast, mice immunized as neonates with 10 mg ofImmunization of mice
an inactivated rabies virus vaccine, i.e., ERA–BPL virus,
Pups were inoculated within 24 hr after birth with 50– failed to develop measurable antibody titers, as shown
75 mg of the pSG5rab.gp vector or phosphate-buffered in Fig. 2.
saline (PBS) or 10 mg of ERA-BPL virus given subcutane- The antibody response to genetic immunization of
ously in a volume of 50 ml. Some of the pups were adult mice persists, at least in some systems, such as
boosted at 3 months of age with 1 mg per mouse of ERA- the one described here, for over a year. The kinetics of
BPL virus or with 50 mg per mouse of pSG5rab.gp vector. the antibody response of neonates to the pSG5rab.gp
vector are shown in Fig. 3. Mice had good titers to rabiesEnzyme-linked immunoadsorbent assay (ELISA)
virus 1 month after immunization, which remained with
Sera obtained by retroorbital bleeding of pups at varied some fluctuation at comparable levels for at least 6
intervals after immunization were tested for antibodies months. Although in the majority of experiments, mice
to rabies virus on microtiter plates coated with inacti- seroconverted after 1 month (as shown in Fig. 3), in some
vated ERA (ERA–BPL) virus, as described (Xiang and experiments, antibodies developed later. This might re-
Ertl, 1992). Antibody isotypes were determined by an flect variability in the inoculation method and thus a dif-
ELISA on ERA virus-coated plates with a 1:200 dilution ference in the number of transfected cells.
of serum using the Calbiochem (LaJolla, CA) Hybridoma Sera were also tested for virus neutralizing activity.
Subisotyping kit according to the manufacturer’s specifi- Titers determined by this method were also stable for at
cations. We tested the reagents provided in this kit using least 5 months (the latest time point tested thus far, data
the Hybridoma Subisotype Control kit, Mouse, also from not shown) ranging between virus neutralizing titers of
Calbiochem. The sensitivity for detection of antibodies 1:15 and 1:135 for pooled sera.
of different isotypes was comparable. To further ensure that genetic immunization of neo-
nates results in stimulation of an immune response, mice
Neutralization assay inoculated at birth with the pSG5rab.gp vector or the
empty control plasmid were boosted at 3 months of ageVirus neutralizing antibody titers were determined by neu-
tralization of the CVS-11 strain of rabies virus prior to infection with a low dose of ERA–BPL virus (1 mg per mouse)
given sc in 100 ml of PBS. In another experiment, miceof BHK-21 cells, as described (Xiang and Ertl, 1992).
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FIG. 1. The antibody response to neonatal immunization. The graph shows the results from three different experiments (I–III). Pups were immunized
within 24 hr after birth with either 50–75 mg of pSG5rab.gp (h) or pSG5 (L) vector. Control mice were inoculated with PBS. Sera of individual mice
from three separate experiments shown in separate graphs were harvested 1 month after immunization and tested for antibodies to rabies virus
by ELISA. Pooled serum from age-matched control pups (j) was used as a control. Data show the optical density { standard deviations.
FIG. 2. The immune response of neonatal mice to inactivated rabies virus. Pups were immunized shortly after birth with 10 mg of ERA–BPL virus.
Immune ( ) as well as age-matched naive (1) pups were bled 6, 10, and 14 weeks later, and antibody titers to rabies virus were determined by
an ELISA. Data were analyzed by Student t test (significance  0.5).
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vaccinated as neonates with the pSG5rab.gp vector sur-
vived a challenge with rabies virus given at 3–4 months
of age, which caused mortality in all of the control ani-
mals (6 of 6).
One recent publications (Sarzotti et al., 1996) reported
that neonates, dependent on the dose of the adminis-
tered antigen, respond preferentially with a Th2-like im-
mune response characterized by lack of stimulation of
cytolytic T cells. Another publication using protein anti-
gen reported qualitatively similar responses in adult and
neonatal mice (Forsthuber et al., 1996). Adult mice re-
spond to genetic immunization with a Th0/Th1-like re-
sponse (Xiang et al., 1992) in which T helper cells secre-
ting IL-2 and interferon-g and B cells producing antibod-
ies of the IgG2a isotype predominate. To further
characterize the immune response of neonates to the
FIG. 3. The kinetics of the antibody response to neonatal immuniza-
genetic vaccine, the isotype profile of the rabies virus-tion. Pups, immunized as described in the legend to Fig. 1, were bled
specific antibodies was determined. As shown in Fig. 5,1 (i), 2 (•), 3 (·), 4 (o), 6 ( ), and 8 (h) months later. Antibody titers
were determined in two separate ELISAs (- - - -, ). Data were the response was predominated by antibodies of the
analyzed by a Student t test (h i • o significance  0.01; · IgG2a isotype, with some IgG1 and IgG2b. A similar anti-
significance  0.05). body isotype profile was seen upon genetic immunization
of adult mice.
were boosted with 50 mg of pSG5rab.gp vector given im Pups developed a vigorous T helper cell response to
at 2 months of age. Mice were bled 14 days later (ERA– rabies virus upon neonatal immunization with the
BPL virus) or 3 months later (pSG5rab.gp) and antibody pSG5rab.gp vector (Table 1). In this experiment, spleno-
titers were determined by an ELISA. As shown in Fig. 4, cytes of individual C3H/He mice immunized neonatally
pups vaccinated at birth with the pSG5rab.gp plasmid with the pSG5rab.gp vector or sham-vaccinated with PBS
developed higher antibody titers to either vaccine used were tested 1 month after immunization for cytokine re-
for booster immunization compared to pups vaccinated lease in response to restimulation with inactivated rabies
at birth with the pSG5 control vector, thus confirming that virus. All of the pSG5rab.gp immunized mice responded
neonatal immunization of pups has a priming effect on with release of cytokines comparable or superior in mag-
the B cell response to rabies virus. nitude to that secreted by pooled lymphocytes of mice
Induction of an immune response to rabies virus was immunized 1 month earlier at 6 to 8 weeks of age with
also confirmed by partial protection of vaccinated neo- the genetic vaccine. The response tested in vitro initially
on the IL-2- and IL-4-sensitive HT-2 cell line were shownnates upon challenge with rabies virus; 6 of 13 mice
FIG. 4. Priming of the immune system by neonatal vaccination with the pSG5rab.gp vector. Mice were immunized at birth with 50 mg of pSG5rab.gp
or pSG5. In one experiment (A) mice were bled at 2 months of age and boosted with 50 mg of pSG5rab.gp. Mice were bled 3 months later and
antibody titers of sera before and after boost were determined [before boost: pSG5 (– – – –); pSG5rab.gp (– – h – –); after boost: pSG5
( — —); pSG5rab.gp ( ). In a second experiment (B), pups were vaccinated at 3 months of age with 1 g of ERA–BPL virus. They were bled
14 days later and serum antibody titers were determined [pSG5/ERA-BPL ( ); pSG5rab.gp/ERA-BPL (h). 1, normal mouse serum.
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some pups failed to respond or developed only marginal
titers. By the same token, the magnitude of the T helper
cell response was fairly inhomogeneous, with stimula-
tion indices ranging from 18 to 86, which presumably
reflects variability in the antigenic load expressed by
transfected cells upon sc inoculation of plasmid DNA.
Neonatal inoculation of some antigen, such as those
expressed on allogeneic or semiallogeneic lymphoid
cells, can induce tolerance, allowing subsequent trans-
plantation of skin grafts syngeneic to the donor lympho-
cytes (Billingham et al., 1953). Inoculation of neonatal
mice with some viruses, such as lymphocytic choriomen-
ingitis virus, causes unresponsiveness of cytolytic T cells
and concomitant stimulation of B cells (Oldstone et al.,
1967), resulting in viral persistence. Other antigens, such
as the hepatitis B virus vaccine in human infants, induce
immunity even if given during the early neonatal period.
Results presented here show that neonatal exposure to
antigen, as presented upon inoculation of plasmid DNA,
can result in specific T and B cell responses. Induction
of immunity in neonatal mice was also described in three
recently published papers using a minor histocompatibil-
ity antigen, i.e., H-Y (Ridge et al., 1996), a live murine
retrovirus (Sarzotti et al., 1996), or the protein antigen
hen egg lysozyme (HEL) (Forsthuber et al., 1996). Vacci-
nation of newborn children to several infectious diseases
would be highly advantageous, but first requires clarifica-
tion of parameters causing activation versus tolerance
of the neonatal immune system. High doses of antigen,
FIG. 5. The antibody isotypes induced by neonatal genetic immuniza- as shown by Sarzotti et al. (1996), seem to favor induction
tion. The isotypes of antibodies to rabies virus from sera of naive mice of Th2 cells with apparent tolerance of cytolytic T cells.
( ), or from mice immunized at birth or at 6–8 weeks of age with 50
mg of pSG5rab.gp (  ) were determined by ELISA using a 1:200 dilution
of serum.
TABLE 1
T Helper Cell Response to Neonatal Immunization
to consist of IL-2; IL-4 could not be detected in the super-
[3H]TdR incorporation (cpm { SD)natants of restimulated lymphocyte cultures using either
the IL-4-dependent CT4S cells as an indicator cell line
Immunization Medium ERA-BPL
or monoclonal antibodies to IL-2 and IL-4 for inhibition
of activation of the HT-2 cells (method described in Xiang pSG5rab.gp 74 { 2 5491 { 132
pSG5rab.gp 55 { 6 1135 { 97et al., 1993). Splenocytes furthermore released low levels
pSG5rab.gp 51 { 11 4389 { 248of interferon-g upon in vitro restimulation (data not
pSG5rab.gp 55 { 5 991 { 17shown). This cytokine profile confirms that genetic immu-
PBS 58 { 17 53 { 9nization of neonates does not induce a Th2-type immune
PBS 133 { 4 138 { 11response but rather a Th0/Th1 response.
PBS 104 { 2 84 { 20
PBS 139 { 19 80 { 5
DISCUSSION Controla 109 { 19 1163 { 195
Data presented here show that a genetic vaccine ex- Note. The data present cytokine release obtained from individual
pressing a viral antigen, i.e., the rabies virus G protein, mice, with the exception of the positive control (amice immunized at 6
to 8 weeks of age with the pSG5rab.gp vector), in which splenocytesinduces upon inoculation of neonatal mice an anti-viral
pooled from three mice were tested. Data reflect triplicate sampleimmune response consisting of T helper cells and anti-
{ SD. Mice were immunized within 24 hr after birth with pSG5rab.gpbodies with a predominance of antibodies of the IgG2a
vector, Adrab.gp virus, or PBS given sc. Mice were euthanized 1 month
isotype, as seen upon genetic immunization of adult later and splenocytes were cultured for 24 hr with medium or 1 mg/ml
mice. Although the majority of pups vaccinated at birth of ERA–BPL virus. Cell-free supernatants were tested for cytokines on
the HT-2 indicator cell line.with the pSG5rab.gp vaccine developed antibodies,
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In the H-Y system (Ridge et al., 1996), tolerance by high mice immunized with the pSG5rab.gp vector, antibodies
are not detected until about 3–4 weeks after immuniza-doses of antigen could be circumvented by presentation
of the male antigen on dendritic cells. The authors argue tion (Xiang et al., 1995). In most experiments, pups inocu-
lated at birth with vector DNA seroconverted within 1that the neonatal immune system that contains only a
few T cells to a given antigen is turned off by the H-Y month, suggesting that activation occurred shortly after
immunization.antigen presented by a large number of foreign spleno-
cytes, most of which lack costimulatory signals. How For practical purposes, vaccination of human neonates
with a single dose of a mixture of plasmid vectors ex-does the hypothesis formulated for the H-Y system (Ridge
et al., 1996) apply to data presented in this paper? Inocu- pressing relevant antigens of all viruses causing com-
mon and preventable childhood infections would belation of mice with a plasmid vector results in expression
of the antigen on comparatively few cells close to the highly advantageous. Immunizations with traditional vac-
cines are generally delayed for several months, not onlysite of inoculation. Expression of the antigen has been
demonstrated histologically on cells such as muscle to accommodate further maturation of the immune sys-
tem, but also to minimize interference of active immuniza-cells (Wolff et al., 1990), but not on dendritic cells, which
is likely to reflect the insensitivity of the experimental tion by maternally transferred antibodies. The effect of
maternally transferred antibodies on neonatal immuniza-approach. Although we have postulated that the vector
DNA must cause expression of antigen on APCs to stimu- tion with genetic vaccines remains to be elucidated.
late an immune response (Xiang and Ertl, 1995), most of
the antigen is presumably expressed by non-APCs and
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